Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Genomic responses from the estrogen-responsive element-dependent signaling pathway mediated by estrogen receptor alpha are required to elicit cellular alterations.

Nott SL, Huang Y, Li X, Fluharty BR, Qiu X, Welshons WV, Yeh S, Muyan M.

J Biol Chem. 2009 May 29;284(22):15277-88. doi: 10.1074/jbc.M900365200.

2.

New insights into the classical and non-classical actions of estrogen: evidence from estrogen receptor knock-out and knock-in mice.

McDevitt MA, Glidewell-Kenney C, Jimenez MA, Ahearn PC, Weiss J, Jameson JL, Levine JE.

Mol Cell Endocrinol. 2008 Aug 13;290(1-2):24-30. doi: 10.1016/j.mce.2008.04.003. Review.

3.

Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways.

Fox EM, Andrade J, Shupnik MA.

Steroids. 2009 Jul;74(7):622-7. doi: 10.1016/j.steroids.2008.10.014. Review.

4.

The many faces of estrogen signaling.

Vrtačnik P, Ostanek B, Mencej-Bedrač S, Marc J.

Biochem Med (Zagreb). 2014 Oct 15;24(3):329-42. doi: 10.11613/BM.2014.035. Review.

5.

Non-nuclear estrogen receptor signaling in the endothelium.

Wu Q, Chambliss K, Umetani M, Mineo C, Shaul PW.

J Biol Chem. 2011 Apr 29;286(17):14737-43. doi: 10.1074/jbc.R110.191791. Review.

6.

DNA Recognition by a Novel Bis-Intercalator, Potent Anticancer Drug XR5944.

Lin C, Yang D.

Curr Top Med Chem. 2015;15(14):1385-97. Review.

7.

Recent insights into non-nuclear actions of estrogen receptor alpha.

Banerjee S, Chambliss KL, Mineo C, Shaul PW.

Steroids. 2014 Mar;81:64-9. doi: 10.1016/j.steroids.2013.11.002. Review.

PMID:
24252382

Supplemental Content

Support Center